Información:
Error:
ID
39959
Descripción
ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling; ODM derived from: https://clinicaltrials.gov/show/NCT01176032
Link
https://clinicaltrials.gov/show/NCT01176032
Palabras clave
Versiones (1)
- 6/3/20 6/3/20 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
6 de marzo de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Hypertension NCT01176032
Eligibility Hypertension NCT01176032
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT01176032
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Hypertensive disease
Item
patient with hypertension
boolean
C0020538 (UMLS CUI [1])
Concentric hypertrophy of left ventricle
Item
confirmed concentric left ventricular hypertrophy:
boolean
C0745681 (UMLS CUI [1])
Left ventricular mass Index | Gender
Item
lvmi > 49.2 g/m2.7 for men and >46.7 g/m2.7 for women
boolean
C0455825 (UMLS CUI [1,1])
C0918012 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
C0918012 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
Ventricular wall thickening Relative
Item
relative wall thickness > 0.42
boolean
C0948228 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0205345 (UMLS CUI [1,2])
Hypertension, severe | Secondary hypertension
Item
sever or secondary htn
boolean
C4013784 (UMLS CUI [1])
C0155616 (UMLS CUI [2])
C0155616 (UMLS CUI [2])
Left ventricular ejection fraction
Item
lv ejection fraction of <40%
boolean
C0428772 (UMLS CUI [1])
Indication Angiotensin-Converting Enzyme Inhibitors | Indication Angiotensin II receptor antagonist | Indication Adrenergic beta-1 Receptor Antagonists
Item
patient with compelling indication to aceis or arbs or bb
boolean
C3146298 (UMLS CUI [1,1])
C0003015 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
C3146298 (UMLS CUI [3,1])
C0304516 (UMLS CUI [3,2])
C0003015 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
C3146298 (UMLS CUI [3,1])
C0304516 (UMLS CUI [3,2])
Myocardial Infarction | Coronary Artery Bypass Surgery | Percutaneous transhepatic cholangiography | Transient Ischemic Attack | Cerebrovascular accident
Item
history of myocardial infarction, coronary artery bypass surgery, ptc intervention, tia or stroke within 6 months of study entry
boolean
C0027051 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
C0203085 (UMLS CUI [3])
C0007787 (UMLS CUI [4])
C0038454 (UMLS CUI [5])
C0010055 (UMLS CUI [2])
C0203085 (UMLS CUI [3])
C0007787 (UMLS CUI [4])
C0038454 (UMLS CUI [5])
Collagen Diseases | Bone Diseases
Item
history of collagenopathies, osteopathy
boolean
C0009326 (UMLS CUI [1])
C0005940 (UMLS CUI [2])
C0005940 (UMLS CUI [2])
Estimated Glomerular Filtration Rate | Serum potassium measurement
Item
egfr <30 ml/min/1,73 m2, serum potassium ≥5,2 meq/l
boolean
C3811844 (UMLS CUI [1])
C0302353 (UMLS CUI [2])
C0302353 (UMLS CUI [2])
Obesity, Morbid | Body mass index
Item
morbid obesity (bmi ≥ 42 kg/m2
boolean
C0028756 (UMLS CUI [1])
C1305855 (UMLS CUI [2])
C1305855 (UMLS CUI [2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])